Breast-sparing surgery using a special dye after chemo
Part of Cancer, Skin clinical trials.
This trial tests a technique where doctors use a special dye (ICG) to guide breast-conserving surgery in patients whose tumors have shrunk enough after chemotherapy. The goal is to remove only the cancer while saving as much healthy breast tissue as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a type of breast cancer that was locally advanced (spread to nearby areas but not far away).
- You received chemotherapy before surgery (called neoadjuvant chemotherapy).
- Your tumor shrank enough after chemo that your doctor thinks breast-conserving surgery (lumpectomy) is possible.
- You are 18 years or older.
- You are physically active enough to do everyday tasks without help (ECOG 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special light and dye to help surgeons find and remove lymph nodes that might contain cancer cells, in women whose breast cancer has come back in the same area after previous surgery.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This study tests whether a special dye called indocyanine green (ICG) can help find sentinel lymph nodes during breast cancer surgery after chemotherapy. It may offer a safer and more effective way to check if cancer has spread.
This trial uses a special dye called ICG that makes cancer glow under a special camera during breast cancer surgery. Doctors want to find the best time to give the dye so they can see the cancer clearly and remove all of it in one operation.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.